Anzeige
Mehr »
Freitag, 26.06.2026 - Börsentäglich über 12.000 News
Tiefseebergbau erfordert echte Offshore-Expertise
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2ALU7 | ISIN: US1266541028 | Ticker-Symbol:
Branche
Konsumgüter
Aktienmarkt
Sonstige
1-Jahres-Chart
CV SCIENCES INC Chart 1 Jahr
5-Tage-Chart
CV SCIENCES INC 5-Tage-Chart
ACCESS Newswire
245 Leser
Artikel bewerten:
(1)

CV Sciences, Inc.: CV Sciences Expands +PlusHLTH Portfolio with Personalized Wellness Solutions for Healthy Aging

Built on the Company's Health Intelligence Approach, the New Products Help Consumers Create Personalized Wellness Routines That Support Overall Health and Long-Term Vitality

SAN DIEGO, CA / ACCESS Newswire / June 25, 2026 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a consumer wellness company specializing in science-backed natural ingredients and products, today announced the expansion of its +PlusHLTH supplement portfolio with additional formulations supporting cellular integrity, metabolism, cognitive health, cardiovascular wellness, and movement.

Health Intelligence is CV Sciences' approach to personalized wellness, combining thoughtful formulations that support key areas of health targeting multiple pathways to support metabolism, brain health, cardiovascular wellness, movement, stress resilience, and vitality.

"With +PlusHLTH, we are building a modern supplement platform designed to support how consumers want to live today, with more energy, better focus, improved resilience, and healthier aging," said Joseph Dowling, Chief Executive Officer of CV Sciences. "These new formulations are designed to work both individually and as targeted wellness stacks, giving consumers a flexible way to personalize support for their specific health goals. This launch represents another important step in expanding CV Sciences' portfolio of science-backed, cannabinoid-free wellness solutions."

The +PlusHLTH line features clinically studied ingredients selected to support key biological systems, including metabolic signaling, cellular energy production, inflammation response, and neurological balance. Ingredients across the portfolio include compounds such as PEA, OEA, NMN, and berberine, each chosen for its role in supporting targeted wellness outcomes.

We are introducing the following new +PlusHLTH products to support a more personalized wellness routine:

  • Pulse: For cardiovascular health and circulation. Pulse supports heart health, circulation, and cellular energy, core drivers of overall vitality and performance. This advanced formula helps support efficient blood flow and energy production, promoting endurance, recovery, and long-term cardiovascular wellness.

  • Cerebral: For long-term brain health and performance. Cerebral is designed for cognitive performance, and long-term brain health by targeting key systems involved in focus and neurol resilience. This advanced formula helps reduce mental fatigue and promote clearer thinking over time.

  • Restore: For cellular energy and healthy aging. Restore supports cellular energy, repair, and resilience as you age. This advanced formula helps maintain efficiency at the cellular level, promoting recovery, vitality, and long-term performance so you can feel and function at your best.

  • Trinity: For muscle, nerve and whole body balance. Trinity restores optimal magnesium levels to support muscle function, nerve signaling, and cellular energy. This blend of three bioavailable forms helps promote recovery, relaxation, and full-body balance for overall performance and resilience.

  • Movement: For mobility and physical comfort. Movement is designed for physical comfort, mobility, and joint health so you can stay active without limitations. Powered by PEA, it helps reduce soreness, support joint function, and improve everyday wellbeing.

  • Regulate: For appetite control and satiety. Regulate supports natural satiety signals and appetite awareness so you can manage hunger and stay on track. Powered by OEA, it helps promote fullness, reduce overeating, and support consistent, balanced eating habits.

The expanded +PlusHLTH portfolio also reflects CV Sciences' broader strategy to deliver science-backed wellness solutions across multiple consumer health categories. By combining targeted formulations, healthy aging support, and the Company's "Health Intelligence" philosophy, +PlusHLTH complements the Company's existing +PlusCBD offerings while expanding CV Sciences' presence in the growing health and wellness market.

For more information, please visit www.pluscbdoil.com/plushlth.html or www.cvsciences.com.

About CV Sciences, Inc.

CV Sciences, Inc. (OTCQB:CVSI) is a consumer wellness company specializing in nutraceuticals and plant-based foods. The Company develops and markets science-backed, natural ingredients and products through a range of B2B and B2C sales channels.

Its +PlusCBD products are sold at select retail locations throughout the United States and, according to SPINS, are the top-selling hemp extract brand in the natural products market. The benefits of +PlusCBD products in healthy people are supported by human clinical research, as well as three published clinical case studies available on PubMed.gov. +PlusCBD was also the first hemp extract supplement brand to invest in the scientific evidence necessary to achieve self-affirmed Generally Recognized as Safe (GRAS) status.

CV Sciences also markets cannabinoid-free supplements under its +PlusHLTH brand, with targeted formulations designed to optimize health, improve performance, and increase vitality. In addition, the Company's Cultured Foods subsidiary specializes in contract manufacturing and branded products for the nutraceutical and plant-based food industries, with distribution primarily across the EU and select international markets. The Company also owns Elevated Softgels, a leading manufacturer of encapsulated softgels and tinctures for the supplement and nutrition industry.

CV Sciences has primary offices and facilities in San Diego, California; Grand Junction, Colorado; and Warsaw, Poland. Additional information is available at www.cvsciences.com and OTCMarkets.com.

Contact Information
ir@cvsciences.com

SOURCE: CV Sciences, Inc.



View the original press release on ACCESS Newswire:
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/cv-sciences-expands-plushlthtm-portfolio-with-personalized-wellness-s-1182682

© 2026 ACCESS Newswire
SpaceX-Hype zu teuer – Diese 5 Aktien bieten bessere Chancen
Raumfahrt-Aktien gehören aktuell zu den heißesten Wetten an den Börsen. Spätestens mit dem spektakulären Börsengang von SpaceX ist der Sektor endgültig im Fokus der Anleger angekommen. Fantasien rund um Satellitenkommunikation, Rechenzentren im All und neue Geschäftsmodelle treiben die Kurse immer weiter nach oben.

Doch während die Begeisterung steigt, werden auch die Risiken größer. Viele Space-Start-ups sind inzwischen extrem hoch bewertet, arbeiten noch nicht profitabel und hängen stark von stetigem Kapitalzufluss ab. Schon kleine Rückschläge könnten die ambitionierten Wachstumspläne ins Wanken bringen.

Für Anleger, die vom Boom der Raumfahrt profitieren wollen, lohnt sich daher ein Perspektivwechsel. Statt auf überhitzte Pure Plays zu setzen, rücken etablierte Konzerne in den Fokus – Unternehmen mit jahrzehntelanger Erfahrung, stabilen Cashflows und engen Verbindungen zu Raumfahrtagenturen wie NASA und ESA.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau dieses Profil erfüllen: solide bewertet, operativ stark und bestens positioniert, um langfristig vom Space-Boom zu profitieren.

Jetzt den kostenlosen Report sichern – bevor der Markt die versteckten Gewinner entdeckt!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.